Arterial stiffness and cardiac function are important predictors of cardiovascular events in patients with hypertension, even with adequate blood pressure (BP) control. We evaluated whether a direct renin inhibitor, aliskiren, reduces arterial stiffness and modulates left ventricular function compared with a diuretic, hydrochlorothiazide, in elderly hypertensive patients. Twenty-one hypertensive patients [67 +/- 14 (SD) yr] were randomly assigned to receive 6-mo aliskiren (n = 11) or hydrochlorothiazide (n = 10)-based therapy. We assessed beta-stiffness of the local arteries, arterial elastance (Ea), and echocar-diographic variables, including early (E) and late (A) mitral inflow velocity, deceleration time of E, early (E') and late (A') diastolic mitral annular velocity, and left ventricular end-systolic elastance (E-es) before and after treatment. BP decreased similarly (P < 0.001) after both therapies. beta-Stiffness of the carotid artery decreased after aliskiren but increased after hydrochlorothiazide treatment (aliskiren: 6.42 +/- 2.34 pre vs. 5.07 +/- 1.29 post; hydrochlorothiazide: 5.05 +/- 1.78 vs. 7.25 +/- 2.68, P = 0.001 for interaction). beta-Stiffness of the femoral and radial arteries were not different after either treatment. Different from aliskiren, E decreased (73 +/- 16 vs. 67 +/- 14 cm/s, P = 0.026), and the deceleration time was prolonged (218 +/- 40 vs. 236 +/- 35 ms, P = 0.032) after hydrochlorothiazide therapy, whereas the E/A, and E' ained unchanged after both treatments. E(a)and E-es decreased after aliskiren therapy (both P=0.05), whereas the E-a/E-es (ventricular-arterial coupling) was maintained after both treatments. Thus, aliskiren decreased the stiffness of carotid artery and left ventricular end-systolic elastance with maintenance of ventriculararterial coupling without any effects on diastolic filling, while hydrochlorothiazide increased carotid arterial stiffness and slowed early diastolic filling in elderly hypertensive patients.